Control of onchocerciasis.

Area of Science:

• Global Health
• Infectious Diseases
• Parasitology

Background:

• Onchocerciasis, a filarial infection, causes severe visual impairment and debilitating skin conditions, impacting 37 countries, predominantly in Africa.
• In 1995, an estimated 17.7 million people were infected, with 270,000 blind and 500,000 visually impaired, contributing to 1 million DALYs.
• Ocular disease accounts for 40% of annual DALYs, highlighting the public health significance of onchocerciasis control.

Purpose of the Study:

• To review the progress and challenges in the global control of onchocerciasis.
• To identify future technical hurdles in disease management and treatment strategies.
• To emphasize the need for improved diagnostics and alternative therapies.

Main Methods:

• Review of historical control programs and drug donation initiatives.
• Analysis of current epidemiological data and public health impact.
• Discussion of emerging challenges in mass drug administration and surveillance.

Main Results:

• Significant progress in onchocerciasis control over the past 30 years, notably in West Africa and the Americas.
• Successful large-scale distribution of ivermectin (Mectizan) through international partnerships.
• Identification of key challenges including managing adverse reactions, expanding treatment to new areas, ensuring sustainability, and detecting resistance.

Conclusions:

• International public-private partnerships and tools like ivermectin have been crucial for onchocerciasis control.
• Future efforts must address complex issues such as co-endemicity with Loa loa, treatment in hypoendemic regions, and long-term surveillance.
• Development of new diagnostic tools and second-line treatments, including macrofilaricides, is essential for sustained disease elimination.